Dear Readers,
The Healthcare Sector continues to be fertile ground for antitrust issues, whether in the case of hospital or pharmaceutical mergers (vertical, cross-market, etc.), pay for delay issues, patent settlements, or parallel exports, etc.
CPI is pleased to present out latest Antitrust Chronicle® focusing on some of these hotly discussed topics in the Healthcare Sector in the United States and Europe.
The DOJ’s Antitrust Division remains focused on anticompetitive practices in the Heal
...THIS ARTICLE IS NOT AVAILABLE FOR IP ADDRESS 13.58.82.79
Please verify email or join us to access premium content!